#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Chronic inflammatory demyelinating polyradiculoneuropathy Demyelination Measles Propionic acidaemia Extra-osseous Ewing's sarcoma recurrent Univentricular heart Friedreich's ataxia Polycystic liver disease Cortical dysplasia Osteosarcoma Bronchiectasis Anal cancer recurrent Congenital nephrogenic diabetes insipidus Emphysema Andersen-Tawil syndrome More trials…
Learn about Rare Diseases

Familial haemophagocytic lymphohistiocytosis – Trials in Disease Sarcoidosis – Diagnostics Andersen-Tawil syndrome – Life with Disease Vascular malformation – Life with Disease Prader-Willi syndrome – Trials in Disease Angiosarcoma Rett syndrome – Trials in Disease Pleural mesothelioma malignant Urea cycle disorder – Life with Disease Pleomorphic leiomyosarcoma – Basic Information More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Nortriptyline Hydrochloride L-Tryptophan Charcoal, Activated Tazobactam Sodium Rosuvastatin Foscarnet Sodium Hexahydrate Hst-1011 IM-101 Sumatriptan Succinate SAR445399 Dexlansoprazole Sodium Iodide (131I) Oxybuprocaine Hydrochloride ZILEBESIRAN Follitropin Delta Amniotic Membrane, Human Paroxetine Hydrochloride Efpegerglucagon Regn7257 Mk-2060 More therapies…

Learn about Your Condition

Haemofiltration BK virus infection HER2 negative breast cancer Medulloblastoma Intracranial aneurysm Malignant mast cell neoplasm Basal cell naevus syndrome Renal cell carcinoma stage IV Acute kidney injury Pulmonary congestion Radius fracture Diarrhoea Hereditary optic atrophy Latent tuberculosis Malignant melanoma stage II More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Clear cell papillary renal cell carcinoma

Study of JK06 for Patients with Advanced or Metastatic Cancer

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Jk06
Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Not recruiting

3 1 1 1
Investigated Drugs:
+2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Clear cell papillary renal cell carcinoma

Study of JK06 for Patients with Advanced or Metastatic Cancer

Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies